COL1A2 and gastric cancer: For example, collagen type I alpha 2 chain (COL1A2) was suggested to be a novel biomarker to enhance the clinical prediction of gastric cancer [28], and collagen type X alpha 1 (COL10A1) might be a key independent predictor of poor over survival of GC patients [29].